Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.34/sh

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.34), versus ($0.58) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Reliance Industries (RELIANCE:IN) PT Raised to INR1,710 at Jefferies
• Goldman Sachs Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Buy